Subdural hematoma in patients with end-stage renal disease receiving hemodialysis

被引：15
|
作者：
Wang, I. -K. [1 ,2 ,3 ]
Lin, C. -L. [4 ,5 ]
Wu, Y. -Y. [6 ]
Kuo, H. -L. [3 ]
Lin, S. -Y. [3 ]
Chang, C. -T. [3 ]
Yen, T. -H. [7 ,8 ]
Chuang, F. -R. [9 ]
Cheng, Y. -K. [10 ]
Huang, C. -C. [3 ]
Sung, F. -C. [1 ,4 ,5 ]
机构：
[1] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung 404, Taiwan
[2] China Med Univ, Coll Med, Dept Internal Med, Taichung 404, Taiwan
[3] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan
[4] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[5] China Med Univ, Coll Publ Hlth, Taichung 404, Taiwan
[6] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung 404, Taiwan
[7] Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan
[8] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[9] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Nephrol,Med Ctr, Kaohsiung, Taiwan
[10] China Med Univ Hosp, Div Neurosurg, Taichung, Taiwan
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2014年 / 21卷 / 06期
关键词：
cohort study; end-stage renal disease; hemodialysis; subdural hematoma; TRAUMATIC BRAIN-INJURY; RISK-FACTORS; FALLS; COMPLICATIONS; MORTALITY; FAILURE;
D O I：
10.1111/ene.12406
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Background and purposeHemodialysis (HD) may increase the risk of acute subdural hematoma (SDH) with high fatality, but the extent of this disease in non-western populations is unclear. The incidence of and fatality from SDH in patients with end-stage renal disease (ESRD) on HD were examined for an Asian population. MethodsA cohort of 4709 newly diagnosed ESRD patients on HD from 1998 to 2010 and a control cohort of 18663 subjects without any kidney disease were identified from a universal insurance claims database in Taiwan. The incidence and hazard of SDH for the two cohorts and 30-day mortality from SDH were measured by the end of 2010. ResultsThe incidence of SDH was 4.47-fold higher in the HD cohort than in the control cohort (56.3 vs. 12.6 per 10000 person-years) with an adjusted hazard ratio (HR) of 3.81 (95% CI2.77-5.25). HD patients with SDH had a high odds of 30-day mortality with an adjusted odds ratio of 6.34 (95% CI 2.37-16.9). ConclusionsESRD patients with HD were demonstrated to be at high risk of subsequent SDH and to have a high mortality risk from SDH. Proper care for HD patients is necessary to prevent the devastating disorder.
引用
收藏
页码：894 / 900
页数：7
相关论文
共 50 条
  • [1] Risk of Subdural Hematoma Expansion in Patients With End-Stage Renal Disease: Continuous Venovenous Hemodialysis Versus Intermittent Hemodialysis
    Ran, Kathleen R.
    Ejimogu, Nna-Emeka
    Yang, Wuyang
    Kilgore, Collin B.
    Nair, Sumil K.
    Monroy Trujillo, Jose M.
    Jackson, Christopher M.
    Mukherjee, Debraj
    Anderson, William S.
    Gallia, Gary L.
    Weingart, Jon D.
    Robinson, Shenandoah
    Cohen, Alan R.
    Bettegowda, Chetan
    Huang, Judy
    Tamargo, Rafael J.
    Xu, Risheng
    [J]. NEUROSURGERY, 2024, 94 (03) : 567 - 574
  • [2] Retrospective analysis of nontraumatic subdural hematoma incidence and outcomes in Egyptian patients with end-stage renal disease on hemodialysis
    Fayed, Ahmed
    Tarek, Ayman
    Refaat, Mohamed, I
    Abouzeid, Sameh
    Salim, Sohail Abdul
    Zsom, Lajos
    Fulop, Tibor
    Soliman, Karim M.
    Elmallawany, Mohamed A.
    [J]. RENAL FAILURE, 2021, 43 (01) : 1322 - 1328
  • [3] Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis
    Teigen, Mette Maja B.
    Duffull, Stephen
    Dang, Lily
    Johnson, David W.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1259 - 1267
  • [4] Survival of patients with AIDS and end-stage renal disease receiving hemodialysis
    Ifudu, O
    Salifu, MO
    Reydel, C
    DiRienzo, R
    McClendon, E
    Bley, A
    Waltrous, C
    Oguagha, C
    Friedman, EA
    [J]. DIALYSIS & TRANSPLANTATION, 2004, 33 (04) : 176 - +
  • [5] Rare but Real: Spontaneous Renal Hematoma in End-Stage Renal Disease Patients on Hemodialysis
    Nessa, Lutfor
    Atodaria, Rahul
    Del Nogal, Genesis Perez
    Mungara, Sai Siva
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01)
  • [6] Clinical Oral Findings in Patients With End-stage Renal Disease Receiving Hemodialysis
    Ferreira da Silva, Luiz Carlos
    de Andrade-Junior, Manoel Pacheco
    Piva, Marta Rabello
    Saquete Martins-Filho, Paulo Ricardo
    Freitas, Roseana de Almeida
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2015, 26 (03) : 966 - 967
  • [7] Validation of Doripenem Dosing in Patients with End-Stage Renal Disease Receiving Hemodialysis
    Heil, Emily L.
    Daniels, Lindsay M.
    Walko, Christine M.
    Nicolau, David P.
    Smith, Edwin A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (11) : 1455 - 1456
  • [8] Vancomycin assay performance in patients with end-stage renal disease receiving hemodialysis
    Kingery, JR
    Sowinski, KM
    Kraus, MA
    Klaunig, JE
    Mueller, BA
    [J]. PHARMACOTHERAPY, 2000, 20 (06): : 653 - 656
  • [9] Nontraumatic subdural hematoma in patients on hemodialysis with end-stage kidney disease: a systematic review and pooled analysis
    Yang, Liling
    Li, Zongping
    Dai, Xiaoyu
    Wang, Lijun
    Wang, Xiaoyi
    Liu, Hongyuan
    [J]. FRONTIERS IN NEUROLOGY, 2023, 14
  • [10] ECONOMIC IMPACT OF PRURITUS AMONG END-STAGE RENAL DISEASE PATIENTS RECEIVING HEMODIALYSIS
    Ramakrishnan, K.
    Sood, V
    Sibbel, S. P.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A632 - A632
12345